Methoxy polyethylene glycol-epoetin beta 75 mcg in 0.3 mL Prefilled Syringe
RxNorm 804171
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 804171 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: methoxy polyethylene glycol-epoetin beta 75 mcg in 0.3 mL Prefilled Syringe.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
0.3 mL methoxy polyethylene glycol-epoetin beta 0.25 mg/ML Prefilled Syringe
(Atom ID: 12343579)
SYPrescribable
Synonym (SY):
Methoxy polyethylene glycol-epoetin beta 0.075 mg per 0.3 mL Prefilled Syringe
(Atom ID: 3043973)
PSNPrescribable
Prescribable Name (PSN):
Methoxy polyethylene glycol-epoetin beta 75 mcg in 0.3 mL Prefilled Syringe
(Atom ID: 6835906)
SYPrescribable
Synonym (SY):
Methoxy polyethylene glycol-epoetin beta 75 mcg per 0.3 mL Prefilled Syringe
(Atom ID: 3043974)
Patient Education
Methoxy Polyethylene Glycol-Epoetin Beta Injection
Methoxy polyethylene glycol-epoetin beta injection is used to treat anemia (a lower than normal number of red blood cells) in people with chronic kidney failure (condition in which the kidneys slowly and permanently stop working over a period of time) in adults on and not on dialysis and in children 5 years of age and older on dialysis who have already received another treatment for anemia. Methoxy polyethylene glycol-epoetin beta injection should not be used to treat anemia caused by cancer chemotherapy and should not be used in place of a red blood cell transfusion to treat severe anemia. Methoxy polyethylene glycol-epoetin beta injection is in a class of medications called erythropoiesis-stimulating agents (ESAs). It works by causing the bone marrow (soft tissue inside the bones where blood is made) to make more red blood cells.
[Learn More]
* Please review the disclaimer below.